| Literature DB >> 36201485 |
Fatma O Khalil1, Muhammad B Taj2, Enas M Ghonaim1, Shimaa Abed El-Sattar3, Sally W Elkhadry4, Hala El-Refai1, Omar M Ali5, Ahmed Salah A Elgawad6, Heba Alshater7.
Abstract
Till now the exact mechanism and effect of biogenic silver nanoparticles on fungus is an indefinable question. To focus on this issue, the first time we prepared hydrothermal assisted thyme coated silver nanoparticles (T/AgNPs) and their toxic effect on Candida isolates were determined. The role of thyme (Thymus Vulgaris) in the reduction of silver ions and stabilization of T/AgNPs was estimated by Fourier transforms infrared spectroscopy, structure and size of present silver nanoparticles were detected via atomic force microscopy as well as high-resolution transmission electron microscopy. The biological activity of T/AgNPs was observed against Candida isolates from COVID-19 Patients. Testing of virulence of Candida species using Multiplex PCR. T/AgNPs proved highly effective against Candida albicans, Candida kruzei, Candida glabrata and MIC values ranging from 156.25 to 1,250 μg/mL and MFC values ranging from 312.5 to 5,000 μg/mL. The structural and morphological modifications due to T/AgNPs on Candida albicans were detected by TEM. It was highly observed that when Candida albicans cells were subjected to 50 and 100 μg/mL T/AgNPs, a remarkable change in the cell wall and cell membrane was observed.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36201485 PMCID: PMC9536612 DOI: 10.1371/journal.pone.0269864
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Synthesis of T/AgNPs by plant extract.
Primers sequences, target genes, amplicon sizes and cycling conditions.
| Target gene | Primers sequences | Amplified segment (bp) | Primary denaturation | Amplification (35 cycles) | Final extension | ||
|---|---|---|---|---|---|---|---|
| Secondary denaturation | Annealing | Extension | |||||
|
| 122 | 94°C | 94°C | 60°C | 72°C | 72°C | |
|
| |||||||
|
| 106 | 94°C | 94°C | 60°C | 72°C | 72°C | |
|
| |||||||
|
| 243 | 94°C | 94°C | 55°C | 72°C | 72°C | |
|
| |||||||
|
| 394 | 94°C | 94°C | 49°C | 72°C | 72°C | |
|
| |||||||
Fig 2UV-vis spectra of plant extract (green) and silver nanoparticles (red).
Fig 3FTIR spectrum of plant extract (red) and silver nanoparticles (green).
Fig 4HRTEM image of silver nanoparticles.
Fig 5AFM images of Thyme based silver nanoparticles (T/AgNPs).
“The AFM images display dense aggregates of quasi-spherical AgNPs with an average size of 22 nm. The aggregation shown in AFM images is attributed to the sampling process for AFM leading to dropping a few drops of NPs solution on a silica glass plate and allowing drying to get a thin film of NPs. This will allow the NPs to be clustered together. The AFM images confirm the narrow particle size distribution obtained from TEM images”.
Fig 6Selected disks show the disk diffusion (antibacterial) activity of silver nanoparticles.
(A) Inhibition zone present around the disc dipped in AgNPs and (B) inhibition zone absent around the disc (control).
Fig 7TEM images of the effect of Thymus vulgaris silver nanoparticles on Candida; destruction of the fungal cell wall with disruption of membrane.
Fig 8TEM images of SIL (Solid Immersion Lens) showing shrinkage of Candida albicans isolates after addition of biologically active silver nitrate particles.
Fig 11TEM images of intracellular and extracellular distribution of biologically active silver nitrate (measured cells are disrupted).
Demographic, clinical-laboratory data, and prognosis of patient groups.
| Category | Result | Total | Test | p-value | ||
|---|---|---|---|---|---|---|
| Patients without fungal growth | Patients with fungal growth | |||||
| Sex | Male | 9 64.3% | 32 69.6% | 41 68.3% | X2 = 0.138 | 0.749 |
| Age | Mean ± Std Deviation | 50.93±6.866 | 51.96±7.489 | 51.72±7.305 | U = 0.315 | 0.753 |
| Sample | Ascitic | 0(0.0%) | 1(2.2%) | 1(1.7%) | LR = 3.7 | 0.589 |
| Nasal SARSCOV2PCR | Negative | 0 (0.0%) | 1 | 1 | Fisher = 0.31 | 0.767 |
| RBS | Mean± | 107.29 | 119.09 | 116.33 | U = 0.861 | 0.39 |
| CRP | Mean± | 50.57 | 53.67 | 52.91 | U = 0.195 | 0.845 |
| CBC(WBCS) | Mean± | 7.014 | 7.941 | 7.725 | U = 2.258 | 0.024* |
| Lymphocytes | Mean±SD | 68.186±160.9142 | 21.843±12.0892 | 32.657±78.7876 | U = 1.19 | 0.234 |
| ESR | Mean±SD | 47.71±30.139 | 45.04±30.663 | 45.67±30.308 | U = 0.307 | 0.759 |
| serum ferritin | Mean±SD | 542.93±231.288 | 553.07±291.897 | 550.70±277.113 | U = 0.105 | 0.916 |
| D-Dimer | Mean±SD | 23.2857±80.22222 | 8.6972±44.2214 | 12.1012±54.2977 | U = 0.74 | 0.459 |
| LDH | Mean±SD | 543.64±186.578 | 640.04±262.926 | 617.55±249.173 | U = 1.006 | 0.315 |
| Prognosis | Death | 0 0.0% | 4 8.7% | 4 6.7% | Fisher = 1.3 | 0.564 |
The sociodemographic, laboratory, antifungal sensitivity, virulence factors in Candida albicans versus Candida non-albicans isolates.
| Category |
| Total | Test | p-value | ||
|---|---|---|---|---|---|---|
| Sex | Male | 24 | 5 | 29 | X2 = 1.8 | 0.179 |
| Age | Mean | 52.12 | 50.00 | 51.63 | U = 0.403 | 0.702 |
| Sample | ascitic | 1 | 0 | 1 | LH = 2.7 | 0.745 |
| CORAD | 4 | 31 | 9 | 40 | Fisher = 0.184 | 0.558 |
| Nasal SARSCOV2PCR | Negative | 1 | 0 | 1 | Fisher = 0.31 | 1.00 |
| RBS | Mean± | 118.00 | 113.60 | 116.98 | U = 0.202 | 0.840 |
| CRP | Mean± | 55.69 | 52.67 | 55.02 | U = 0.315 | 0.752 |
| CBC(WBCS) | Mean± | 7.679 | 9.440 | 8.088 | U = 1.497 | 0.134 |
| Lymphocytes | Mean± | 22.339 | 16.700 | 21.028 | U = 0.792 | 0.428 |
| ESR | Mean± | 46.67 | 44.60 | 46.19 | U = 0.217 | 0.829 |
| serum ferritin | Mean± | 569.61 | 514.80 | 556.86 | U = 0.374 | 0.708 |
| D-Dimer | Mean± | 11.3052 | 2.2000 | 9.1877 | U = 0.207 | 0.836 |
| LDH | Mean± | 645.88 | 703.10 | 659.19 | U = 0.504 | 0.615 |
| Fluconazole | S | 20 | 3 | 23 | X2 = 2.89 | 0.089 |
| Miconazole | S | 19 | 2 | 21 | X2 = 4.337 | 0.037* |
| Nystatin | S | 23 | 4 | 27 | X2 = 2.897 | 0.089 |
| Clotrimazole | S | 18 | 3 | 21 | X2 = 1.85 | 0.174 |
| Fluocytosin | S | 9 | 1 | 10 | X2 = 1.28 | 0.257 |
| RAS1 | Negative | 0 | 5 | 5 | Fisher = 18.6 | 0.0001** |
| ALS3 | Negative | 0 | 4 | 4 | Fisher = 14.55 | 0.002** |
| Hyr1 | Negative | 3 | 7 | 10 | X2 = 15.9 | 0.0001** |
| SAP4 | Negative | 1 | 4 | 5 | Fisher = 10.2 | 0.007** |
| biosynthetic anti-fungal | S | 21 | 5 | 26 | X2 = 0.597 | 0.44 |
| Silver nanoparticles plus biosynthetic | S | 31 | 9 | 40 | X2 = 0.573 | 1.00 |
| Prognosis | death | 0 | 4 | 4 | Fisher = 14.55 | 0.002** |
Fig 12(A) The percentage of resistant isolates to chemical antifungal agents and T/AgNPs. (B) Anti-fungal sensitivity testing of commercial antifungal versus biogenic silver nitrate.
Fig 13Gel electrophoresis of Candida virulence genes, Secreted Aspartic Protease gene (SAP4) was detected at 394 bp, RAS1 was detected at 106 bp, Hyphal-Associated Adhesin (HYR1) gene was detected at 243 bp and agglutinin-like sequence gene (ALS3) was detected at 122 bp.